2019 REGISTERED DIRECT OFFERING - Additional information (Details) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
May 12, 2019 |
Sep. 30, 2021 |
Sep. 30, 2020 |
|
| Derivative Liability | $ 1,628,113 | ||
| Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) | $ 108,944 | $ 679,271 | |
| Registered Direct Offering 2019 [Member] | |||
| Number of shares issued during the period | 8,615,384 | ||
| Shares Issued, Price Per Share | $ 0.325 | ||
| Registered Direct Offering 2019 [Member] | Series H Warrant [Member] | |||
| Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.40 | ||
| Warrants to purchase shares of Common Stock | 1 | ||
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per share or per unit amount of equity securities issued. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|